NTX-253
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NTX-253, covering 2026-01-15 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia [EARLY_Phase 1]